OPV Pharmaceutical Joint Stock Comp Pharmaceutical Import Profile — Vietnam (DGFT 2022–2026)

Name: OPV Pharmaceutical Joint Stock Comp Pharmaceutical Import Records from India — 2 Products, $304.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

OPV Pharmaceutical Joint Stock Comp — Pharmaceutical Importer Profile (2026) | 2 Products, $304.9K Trade | TransData Nexus

OPV Pharmaceutical Joint Stock Comp

Pharmaceutical Importer · Vietnam · Advanced Oncology Focus · $304.9K Total Trade · DGFT Verified

OPV Pharmaceutical Joint Stock Comp is a pharmaceutical importer based in Vietnam with a total trade value of $304.9K across 2 products in 2 therapeutic categories. Based on 7 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. OPV Pharmaceutical Joint Stock Comp sources from 6 verified Indian suppliers, with Naprod Life Sciences Private Limited accounting for 54.3% of imports.

OPV Pharmaceutical Joint Stock Comp — Import Portfolio & Supplier Network

OPV Pharmaceutical Joint Stock Comp import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to OPV Pharmaceutical Joint Stock Comp?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Naprod Life Sciences Private Limited	$643.5K	26	54.3%
Cipla Limited	$316.9K	25	26.7%
Mylan Laboratories Limited

What Formulations Does OPV Pharmaceutical Joint Stock Comp Import?

Formulation	Value	Ships
Esovex 40 [esomeprazole sodium for injection 40MG] [42800	$56.6K	3
Esovex 40 [esomeprazole sodium for injection 40MG] [42750	$56.5K	3
Esovex 40 [esomeprazole sodium for injection 40MG] [42450	$56.1K	3
Myvelpa sofosbuvir 400MG velpatasvir 100MG 28bt packs	$50.0K	1
Ampholip 50MG (amphotericin b lipid complex injection i.v) [Pack size : 10ML x	$50.0K	1
Myvelpa sofosbuvir 400MG velpatasvir 100MG 28bt packs 3000.	$50.0K	1
Pexate 500 (pemetrexed disodium for injection 500MG) (7172 vials)	$50.0K	1
Naprocap 500 (capecitabine tablets USP 500MG)(28728 bottelx10=287280 tabs)	$41.4K	1
Esovex 40 [ esomeprazole sodium for injection 40MG ] [ 85670 vials	$38.1K	1
Esovex 40 [ esomeprazole sodium for injection 40MG ] [ 85400 vials	$38.0K	1
Esovex 40 [esomeprazole sodium for injection 40MG] [85500	$38.0K	1
Esovex 40 [esomeprazole sodium for injection 40MG] [85000	$37.8K	1
Esovex 40 [ esomeprazole sodium for injection 40MG ] [ 84450 vials	$37.6K	1
Esovex 40 [esomeprazole sodium for injection 40MG] [83900	$37.3K	1
Lomac 20 CAPS ( omeprazole 20 MG) (inv.qty.11820 Pack 10 x 10s =1182000 nos)	$33.8K	1

OPV Pharmaceutical Joint Stock Comp imports 45 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Pemetrexed	Advanced Oncology	$204.9K	5	0.7%	18
2	Velpatasvir	Antiviral & HIV Medications	$100.0K	2	0.4%	6

OPV Pharmaceutical Joint Stock Comp imports 2 pharmaceutical products across 2 categories into Vietnam totaling $304.9K.

OPV Pharmaceutical Joint Stock Comp — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

OPV Pharmaceutical Joint Stock Company, established in 1950, is one of Vietnam's oldest and most reputable pharmaceutical firms. Headquartered in Bien Hoa City, Dong Nai Province, the company operates under the legal name CÔNG TY CỔ PHẦN DƯỢC PHẨM OPV. In July 2021, OPV was acquired by RV Group, a strategic move aimed at enhancing its market presence and operational capabilities. The company specializes in the manufacture and distribution of pharmaceutical products, including both over-the-counter (OTC) and prescription medications, across various therapeutic categories. OPV's commitment to quality is evident in its WHO-GMP certified manufacturing facilities, ensuring adherence to international standards. (opv.vn)

2Distribution Network

OPV Pharmaceutical Joint Stock Company maintains a robust distribution network within Vietnam, with its primary manufacturing facility located in Bien Hoa II Industrial Park, Dong Nai Province. This strategic location facilitates efficient logistics and supply chain operations. The company also operates branch offices in major cities, including Ho Chi Minh City and Hanoi, enhancing its reach and responsiveness to market demands. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, OPV's extensive distribution network underscores its capacity to serve a wide geographic area within Vietnam.

3Industry Role

OPV Pharmaceutical Joint Stock Company plays a multifaceted role in Vietnam's pharmaceutical supply chain. As a manufacturer, it produces a diverse range of pharmaceutical products, including both OTC and prescription medications. Additionally, OPV engages in contract manufacturing and marketing services, collaborating with multinational pharmaceutical companies to produce and distribute their products in the Vietnamese market. This dual approach positions OPV as a key player in both domestic production and international partnerships, contributing significantly to the availability and accessibility of pharmaceutical products in Vietnam. (opv.vn)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — OPV Pharmaceutical Joint Stock Comp

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

OPV Pharmaceutical Joint Stock Company demonstrates a high degree of sourcing concentration, with its top five products accounting for 100% of its imports from India. This indicates a strategic focus on specific high-value medications, notably Pemetrexed and Velpatasvir, which together constitute the entire import portfolio. Such concentration may offer benefits like streamlined procurement processes and stronger supplier relationships. However, it also introduces risks associated with dependency on a limited number of suppliers and products. The shipment data reveals a stable relationship with Indian suppliers, as evidenced by multiple shipments over the years. Nonetheless, the absence of diversification in product sourcing could expose OPV to supply chain disruptions or market fluctuations affecting these specific products.

2Supply Chain Resilience

The resilience of OPV Pharmaceutical Joint Stock Company's supply chain is closely tied to its sourcing strategy. With a concentrated import portfolio from India, the company faces potential vulnerabilities related to supplier dependency and geopolitical factors. The limited number of suppliers and formulations imported suggests a lack of diversification, which could impact the company's ability to adapt to supply chain disruptions. Additionally, the reliance on specific shipping routes and regulatory compliance of key suppliers further influences the supply chain's robustness. To enhance resilience, OPV may consider diversifying its supplier base and product range, thereby mitigating risks associated with over-reliance on a narrow segment of the market.

Importing Pharmaceuticals into Vietnam — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Vietnam

1Regulatory Authority & Framework

In Vietnam, the pharmaceutical industry is regulated by the Ministry of Health, which oversees the Drug Administration of Vietnam (DAV). The primary legislation governing pharmaceutical imports is the Law on Pharmacy No. 105/2016/QH13, enacted on April 6, 2016. This law outlines the requirements for pharmaceutical business activities, including importation, distribution, and manufacturing. Decree No. 54/2017/NĐ-CP, issued on May 8, 2017, provides detailed provisions for implementing the Law on Pharmacy, specifying conditions for obtaining import licenses and other regulatory requirements. Additionally, Circular No. 32/2018/TT-BYT, issued on October 12, 2018, regulates the registration of drugs, including the submission of dossiers for market authorization. (hmlf.vn)

2Import Licensing & GMP

To import pharmaceutical products into Vietnam, companies must obtain an import license from the Ministry of Health, as stipulated by the Law on Pharmacy 2016. This license is granted based on specific conditions outlined in Decree No. 54/2017/NĐ-CP. Furthermore, imported drugs must be registered with the Drug Administration of Vietnam (DAV) and granted Market Authorization (MA) before distribution. The registration process involves submitting a dossier that includes detailed information about the drug and its safety, as specified in Articles 54, 55, and 56 of the Law on Pharmacy 2016, supported by Circular No. 32/2018/TT-BYT. (hmlf.vn)

OPV Pharmaceutical Joint Stock Comp — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

OPV Pharmaceutical Joint Stock Company's focus on importing Pemetrexed and Velpatasvir aligns with strategic objectives to cater to specialized therapeutic areas, particularly in oncology and antiviral treatments. The market demand for these medications is driven by the increasing prevalence of cancer and viral infections in Vietnam, necessitating access to effective and affordable treatments. By concentrating on these high-demand products, OPV aims to address critical healthcare needs while positioning itself as a key supplier in these therapeutic segments.

2Sourcing Profile

OPV Pharmaceutical Joint Stock Company employs a sourcing strategy that emphasizes high-value generic drugs, focusing on specific formulations that address significant health concerns in Vietnam. The company's preference for importing finished pharmaceutical formulations, rather than raw active pharmaceutical ingredients (APIs), suggests a strategic decision to ensure product quality and regulatory compliance. India's established pharmaceutical manufacturing capabilities and adherence to international quality standards make it a suitable partner for OPV's procurement needs.

3Market Positioning

Seller's Guide — How to Become a Supplier to OPV Pharmaceutical Joint Stock Comp

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with OPV Pharmaceutical Joint Stock Company, particularly in the supply of Pemetrexed and Velpatasvir. Given OPV's concentrated sourcing strategy, Indian exporters can position themselves as alternative suppliers by offering these specific products, potentially filling gaps in OPV's current sourcing. However, the lack of diversification in OPV's sourcing pattern may limit the company's flexibility in responding to market changes or expanding its product offerings. Indian exporters should consider offering a broader range of products to meet potential gaps in OPV's current sourcing strategy.

2Requirements & Qualifications

Indian exporters seeking to supply OPV Pharmaceutical Joint Stock Company must ensure that their products are registered with the Drug Administration of Vietnam (DAV) and have obtained Market Authorization (MA). Compliance with Good Manufacturing Practice (GMP) standards, such as EU GMP, WHO GMP, or PIC/S, is essential to meet Vietnamese regulatory requirements

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — OPV Pharmaceutical Joint Stock Comp

What products does OPV Pharmaceutical Joint Stock Comp import from India?

OPV Pharmaceutical Joint Stock Comp imports 2 pharmaceutical products across 2 categories. Top imports: Pemetrexed ($204.9K), Velpatasvir ($100.0K).

Who supplies pharmaceuticals to OPV Pharmaceutical Joint Stock Comp from India?

OPV Pharmaceutical Joint Stock Comp sources from 6 verified Indian suppliers. The primary supplier is Naprod Life Sciences Private Limited (54.3% of imports, $643.5K).

What is OPV Pharmaceutical Joint Stock Comp's total pharmaceutical import value?

OPV Pharmaceutical Joint Stock Comp's total pharmaceutical import value from India is $304.9K, based on 7 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does OPV Pharmaceutical Joint Stock Comp focus on?

OPV Pharmaceutical Joint Stock Comp imports across 2 categories. The largest: Advanced Oncology (67.2%), Antiviral & HIV Medications (32.8%).

Get Full OPV Pharmaceutical Joint Stock Comp Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.